Short-course-based TNT with or without PD-1 inhibitor for pMMR locally advanced rectal cancer: Phase 2 results of a randomized trial (STELLAR II)

Post time 5 day(s) ago

journal：Med

Authors：Yuan Tang; Hao-Yue Li; Li-Chun Wei; Ning Li; Wen-Jue Zhang; Yu-Fei Lu; Fei-Yan Deng; Tong-Zhen Xu; Jia-Cheng Shuai; Zi-Fa Lei; Xian-Yu Meng; Shu-Nan Qi; Yong-Wen Song; Wen-Wen Zhang; Hao Jing; Gong Li; Shi-Xin Liu; Ying-Jie Wang; Zheng Liu; Hui-Ying Ma; Ning-Yu Wang; Bo Chen; Shu-Lian Wang; Ye-Xiong Li; Li-Na Zhao; Jian-Qiang Tang; Zheng Jiang; Ying-Gang Chen; Hai-Tao Zhou; Chen Hu; Jing Jin

Published date：2025-11-

DOI：10.1016/j.medj.2025.100807

PDF link：https://www.sciencedirect.com/sc ... 66663402500234X/pdf

Article link：https://doi.org/10.1016/j.medj.2025.100807

Article Source：Elsevier BV。

Remark：

Post time 5 day(s) ago

: This post has been completed
Completed attachments will be deleted within 24 hours.

[Elsevier] Short-course-based TNT with or without PD-1 inhibitor for pMMR locally advanced rectal cancer: Phase 2 results of a randomized trial (STELLAR II)

Best Answer

Same Category

Latest Reply

Announcement

Daily Top Contributors

[Elsevier] Short-course-based TNT with or without PD-1 inhibitor for pMMR locally advanced rectal cancer: Phase 2 results of a randomized trial (STELLAR II) Copy

Best Answer

Same Category

Latest Reply

Announcement

Daily Top Contributors

[Elsevier] Short-course-based TNT with or without PD-1 inhibitor for pMMR locally advanced rectal cancer: Phase 2 results of a randomized trial (STELLAR II)